Fixed Price IPO | ₹11 Cr | Listed at NSE SME | Tue, Nov 7, 2023 - Thu, Nov 9, 2023
Sunrest Lifescience IPO is a fixed price issue of ₹10.85 crores. The issue is entirely a fresh issue of 0.13 crore shares of ₹10.85 crore.
Sunrest Lifescience IPO bidding started from Nov 7, 2023 and ended on Nov 9, 2023. The allotment for Sunrest Lifescience IPO was finalized on Nov 15, 2023. The shares got listed on NSE SME on Nov 20, 2023.
Sunrest Lifescience IPO price is ₹84 per share. The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹1,34,400 (1600 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (3,200 shares), amounting to ₹2,68,800.
Mark Corporate Advisors Pvt.Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Svcm Securities Pvt.Ltd..
Refer to Sunrest Lifescience IPO RHP for detailed Information.
IPO Open
Tue, Nov 7, 2023
IPO Close
Thu, Nov 9, 2023
Issue Price
₹84 per share
Market Cap (Pre-IPO)
₹36.05 Cr
| IPO Date | 7 to 9 Nov, 2023 |
| Listed on | Mon, Nov 20, 2023 |
| Face Value | ₹10 per share |
| Issue Price | ₹84 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Total Issue Size | 12,91,200 shares (agg. up to ₹11 Cr) |
| Reserved for Market Maker | 65,600 shares Svcm Securities Pvt.Ltd. (agg. up to ₹0.5510 Cr) |
| Fresh Issue (Ex Market Maker) | 12,25,600 shares (agg. up to ₹10 Cr) |
| Net Offered to Public | 12,25,600 shares (agg. up to ₹10 Cr) |
| Share Holding Pre Issue | 30,00,000 shares |
| Share Holding Post Issue | 42,91,200 shares |
| NSE Symbol | SUNREST |
| ISIN | INE0PLZ01012 |
Sunrest Lifescience IPO comprises a total issue size of 12,91,200 shares. The net offer to the public is 12,25,600 shares, after excluding 65,600 shares allotted on a firm basis. Of the Net offer 6,12,800 (50.00%) allocated to NII 6,12,800 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 6,12,800 | 50.00% | 47.46% |
| Retail Shares Offered | 6,12,800 | 50.00% | 47.46% |
| Firm Reservations | |||
| Market Maker Shares Offered | 65,600 | 5.08% | |
| Total Shares Offered | 12,91,200 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,600 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,34,400 |
| Retail (Max) | 1 | 1,600 | ₹1,34,400 |
| HNI (Min) | 2 | 3,200 | ₹2,68,800 |
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
| Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 17.06 | 16.71 | 13.02 | 9.48 |
| Total Income | 5.64 | 24.67 | 26.91 | 16.95 |
| Profit After Tax | 0.75 | 2.04 | 0.78 | 0.17 |
| NET Worth | 3.87 | 3.12 | 1.07 | 0.29 |
| Reserves and Surplus | 0.87 | 0.12 | 1.06 | 0.28 |
| Total Borrowing | 3.47 | 2.14 | 3.24 | 2.32 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Meeting Working Capital Requirements | 8.55 |
| 2 | General Corporate Purpose | 1.40 |
| KPI | |
|---|---|
| ROE | 53% |
| ROCE | 98% |
| Debt/Equity | 0.64 |
| RoNW | 65.59% |
| PAT Margin | 8.00% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 6.81 | |
| P/E (x) | 12.33 | 12 |
| Promoter Holding | 100% | 69.91% |
| Market Cap | ₹36.05 Cr. |
The Sunrest Lifescience IPO is subscribed 48.54 times on November 9, 2023 7:29:00 PM (Day 3). The public issue subscribed 65.74 times in the retail category, [.] times in the QIB category, and 29.17 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 29.17 | 6,12,800 | 1,78,78,400 |
| Retail | 65.74 | 6,12,800 | 4,02,86,400 |
| Total | 48.54 | 12,25,600 | 5,94,94,400 |
Total Application : 25,179
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to the Lead Manager (including underwriting commission) | 0.30 |
| 2 | Brokerage, selling commission and upload fees | 0.12 |
| 3 | Fees payable to the Legal Advisors to the Issue | 0.03 |
| 4 | Fees to the Registrar to the Issue | 0.03 |
| 5 | Fees payable to the Regulators including stock exchanges | 0.07 |
| 6 | Printing and distribution of Issue stationary | 0.05 |
| 7 | Advertising and Marketing Expenses | 0.25 |
| 8 | Processing fees to SCSBs for ASBA Applications procured by the members of the Syndicate or Registered Brokers and submitted with the SCSBs | 0.01 |
| 9 | Processing fees to Issuer banks for UPI Mechanism w.r.t application Forms procured by the members of the Syndicate, Registered Brokers, RTAs or the CDPs and submitted to them | 0.01 |
| 10 | Others (bankers to the Issue, auditor’s fees etc.) | 0.03 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹84.00 |
| Open | ₹84.00 |
| Low | ₹79.80 |
| High | ₹84.00 |
| Last Trade | ₹79.80 |
Lead Manager Reports
Sunrest Lifescience IPO is a SME IPO of 12,91,200 equity shares of the face value of ₹10 aggregating up to ₹11 Crores. The issue is priced at ₹84 per share. The minimum order quantity is 1600.
The IPO opens on Tue, Nov 7, 2023, and closes on Thu, Nov 9, 2023.
Skyline Financial Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Sunrest Lifescience IPO using UPI as a payment gateway. Zerodha customers can apply in Sunrest Lifescience IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sunrest Lifescience IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sunrest Lifescience IPO opens on Tue, Nov 7, 2023 and closes on Thu, Nov 9, 2023.
Sunrest Lifescience IPO lot size is 1600, and the minimum amount required for application is ₹1,34,400.
You can apply in Sunrest Lifescience IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Sunrest Lifescience IPO will be done on Wednesday, November 15, 2023, and the allotted shares will be credited to your demat account by Fri, Nov 17, 2023. Check the Sunrest Lifescience IPO allotment status.
The Sunrest Lifescience IPO listing date is on Mon, Nov 20, 2023.
